Home/Filings/4/0001104659-16-097376
4//SEC Filing

Vitae Pharmaceuticals, Inc 4

Accession 0001104659-16-097376

CIK 0001157602operating

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:39 PM ET

Size

5.6 KB

Accession

0001104659-16-097376

Insider Transaction Report

Form 4
Period: 2016-02-15
Fratamico Arthur
Chief Business Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2016-02-15+19,25019,250 total
    Exercise: $8.58Exp: 2026-02-15Common Stock (19,250 underlying)
Footnotes (1)
  • [F1]This option shall vest with respect to 25% of the shares of stock which are subject to this option on February 15, 2017 (the "Initial Vesting Date") and 1/48th of the shares of stock which are subject to this option monthly following the Initial Vesting Date.

Documents

1 file

Issuer

Vitae Pharmaceuticals, Inc

CIK 0001157602

Entity typeoperating

Related Parties

1
  • filerCIK 0001157602

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:39 PM ET
Size
5.6 KB